French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

NCT06287749 · clinicaltrials.gov ↗

RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Resectable
Pancreatic Ductal Adenocarcinoma
Minimal Residual Disease
Liquid Biopsy
ctDNA

Interventions

BIOLOGICAL: Blood sample/Liquid Biopsy

Sponsor

University Hospital, Montpellier